Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Monocrotaline |
EINECS | 628-506-2 |
CAS No. | 315-22-0 | Density | 1.35 g/cm3 |
PSA | 96.30000 | LogP | -0.45470 |
Solubility | 11.86g/L(temperature not stated) | Melting Point |
204 °C |
Formula | C16H23NO6 | Boiling Point | 537.3 °C at 760 mmHg |
Molecular Weight | 325.362 | Flash Point | 278.7 °C |
Transport Information | UN 1544 6.1/PG 3 | Appearance | white to light tan powder |
Safety | 36/37/39-45 | Risk Codes | 25-40 |
Molecular Structure | Hazard Symbols | T | |
Synonyms |
20-Norcrotalanan-11,15-dione,14,19-dihydro-12,13-dihydroxy-, (13a,14a)-;Monocrotaline (6CI,7CI,8CI);(-)-Monocrotaline;2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3,4,5-trimethyl-,[3R-(3R*,4R*,5R*,13aR*,13bR*)]-;Monocrotalin;NSC 28693;Monocrotaline;(13-alpha,14-alpha)-14,19-Dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dione;Crotaline; |
Article Data | 5 |
monocrotaline methylene acetal
monocrotaline
Conditions | Yield |
---|---|
With trityl tetrafluoroborate In dichloromethane for 48h; Heating; | 86% |
With hydrogenchloride; trityl tetrafluoroborate 1.) CH2Cl2, reflux, 48 h, 2.) room temperature, 17.5 h; Yield given. Multistep reaction; |
monocrotaline
Conditions | Yield |
---|---|
With hydrogenchloride In ethylene glycol at 110℃; for 2h; | 75% |
Monocrotaline N-oxide
monocrotaline
Conditions | Yield |
---|---|
With intestinal gut bacteria in a human fecal suspension at 37℃; for 5h; Enzymatic reaction; | 38% |
grahamine
monocrotaline
Conditions | Yield |
---|---|
With hydrogenchloride |
(2R,3R,4R)-2,3,4-trimethyl-2,3-methylenedioxypentanedioic anhydride
monocrotaline
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t. 2: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min 3: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating View Scheme | |
Multi-step reaction with 3 steps 1: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t. 2: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h 3: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating View Scheme |
(2R,3R,4R)-2,3,4-Trimethyl-2,3-(methylenedioxy)pentanedioic acid
monocrotaline
Conditions | Yield |
---|---|
Multi-step reaction with 4 steps 1: Ac2O / CH2Cl2 / 3.5 h / Heating 2: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t. 3: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min 4: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating View Scheme | |
Multi-step reaction with 4 steps 1: Ac2O / CH2Cl2 / 3.5 h / Heating 2: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t. 3: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h 4: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating View Scheme |
(2'R,3R,4S)-5-<2'-methoxy-2'-(trifluoromethyl)phenylacetoxy>-2,3,4-trimethyl-3,4-methylenedioxy-2-pentene
monocrotaline
Conditions | Yield |
---|---|
Multi-step reaction with 8 steps 1: 1) BH3*THF, 2) 3 M NaOH, 30percent H2O2 / 1) THF, 0 deg C, 20 h, 2) THF, r.t., 3 h 2: 1) (COCl)2, DMSO, 2) Et3N / 1) CH2Cl2, -78 deg C, 2 min, 2) CH2Cl2, -78 deg C, 1 h 3: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer 4: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature 5: Ac2O / CH2Cl2 / 3.5 h / Heating 6: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t. 7: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min 8: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating View Scheme | |
Multi-step reaction with 8 steps 1: 1) BH3*THF, 2) 3 M NaOH, 30percent H2O2 / 1) THF, 0 deg C, 20 h, 2) THF, r.t., 3 h 2: 1) (COCl)2, DMSO, 2) Et3N / 1) CH2Cl2, -78 deg C, 2 min, 2) CH2Cl2, -78 deg C, 1 h 3: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer 4: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature 5: Ac2O / CH2Cl2 / 3.5 h / Heating 6: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t. 7: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h 8: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating View Scheme |
(R)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid (4S,5R)-4,5-dimethyl-5-((R)-1-methyl-2-oxo-ethyl)-[1,3]dioxolan-4-ylmethyl ester
monocrotaline
Conditions | Yield |
---|---|
Multi-step reaction with 6 steps 1: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer 2: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature 3: Ac2O / CH2Cl2 / 3.5 h / Heating 4: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t. 5: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min 6: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating View Scheme | |
Multi-step reaction with 6 steps 1: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer 2: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature 3: Ac2O / CH2Cl2 / 3.5 h / Heating 4: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t. 5: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h 6: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating View Scheme |
(2'R,2S,3R,4S)-5-<2'-methoxy-2'-(trifluoromethyl)phenylacetoxy>-2,3,4-trimethyl-3,4-methylenedioxypentanoic acid
monocrotaline
Conditions | Yield |
---|---|
Multi-step reaction with 5 steps 1: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature 2: Ac2O / CH2Cl2 / 3.5 h / Heating 3: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t. 4: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min 5: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating View Scheme | |
Multi-step reaction with 5 steps 1: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature 2: Ac2O / CH2Cl2 / 3.5 h / Heating 3: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t. 4: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h 5: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating View Scheme |
(2'R,3R,4S)-5-<2'-methoxy-2'-(trifluoromethyl)phenylacetoxy>-2,3,4-trimethyl-3,4-methylenedioxy-2-pentanol
monocrotaline
Conditions | Yield |
---|---|
Multi-step reaction with 9 steps 1: 83 percent / POCl3, pyridine / 17 h / 85 °C 2: 1) BH3*THF, 2) 3 M NaOH, 30percent H2O2 / 1) THF, 0 deg C, 20 h, 2) THF, r.t., 3 h 3: 1) (COCl)2, DMSO, 2) Et3N / 1) CH2Cl2, -78 deg C, 2 min, 2) CH2Cl2, -78 deg C, 1 h 4: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer 5: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature 6: Ac2O / CH2Cl2 / 3.5 h / Heating 7: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t. 8: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min 9: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating View Scheme | |
Multi-step reaction with 9 steps 1: 83 percent / POCl3, pyridine / 17 h / 85 °C 2: 1) BH3*THF, 2) 3 M NaOH, 30percent H2O2 / 1) THF, 0 deg C, 20 h, 2) THF, r.t., 3 h 3: 1) (COCl)2, DMSO, 2) Et3N / 1) CH2Cl2, -78 deg C, 2 min, 2) CH2Cl2, -78 deg C, 1 h 4: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer 5: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature 6: Ac2O / CH2Cl2 / 3.5 h / Heating 7: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t. 8: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h 9: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating View Scheme |
The systematic name of Monocrotaline is (3R,4R,5R,13aR,13bR)-4,5-dihydroxy-3,4,5-trimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione. With the CAS registry number 315-22-0, it is also named as (13-alpha,14-alpha)-14,19-Dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dione. The product's category is Miscellaneous Natural Products. Besides, it is white to light tan powder, which should be stored in sealed and dry place at 2-8 °C. This chemical is anticarcinoma drug that is used for biochemical research. In addition, its molecular formula is C16H23NO6 and molecular weight is 325.35692.
Physical properties about Monocrotaline are: (1)ACD/LogP: -4.137; (2)ACD/LogD (pH 5.5): -4.76; (3)ACD/LogD (pH 7.4): -4.15; (4)ACD/BCF (pH 5.5): 1.00; (5)ACD/BCF (pH 7.4): 1.00; (6)ACD/KOC (pH 5.5): 1.00; (7)ACD/KOC (pH 7.4): 1.00; (8)#H bond acceptors: 7; (9)#H bond donors: 2; (10)#Freely Rotating Bonds: 2; (11)Index of Refraction: 1.586; (12)Molar Refractivity: 80.3 cm3; (13)Molar Volume: 239.352 cm3; (14)Polarizability: 31.834 10-24cm3; (15)Surface Tension: 59.2760009765625 dyne/cm; (16)Density: 1.359 g/cm3; (17)Flash Point: 278.731 °C; (18)Enthalpy of Vaporization: 93.63 kJ/mol; (19)Boiling Point: 537.27 °C at 760 mmHg
When you are using this chemical, please be cautious about it as the following: it is toxic if swallowed. Limited evidence of a carcinogenic effect. You should wear suitable protective clothing, gloves and eye/face protection. Moreover, in case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
You can still convert the following datas into molecular structure:
(1)InChI=1S/C16H23NO6/c1-9-13(18)23-11-5-7-17-6-4-10(12(11)17)8-22-14(19)16(3,21)15(9,2)20/h4,9,11-12,20-21H,5-8H2,1-3H3/t9-,11+,12+,15+,16-/m0/s1;
(2)InChIKey=QVCMHGGNRFRMAD-XFGHUUIASA-N;
(3)Smiles[C@@H]12[C@H]3CCN1CC=C2COC(=O)[C@]([C@]([C@H](C(=O)O3)C)(C)O)(C)O
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mammal (species unspecified) | LDLo | unreported | 60mg/kg (60mg/kg) | Pharmacological Reviews. Vol. 22, Pg. 429, 1970. | |
mouse | LD50 | intraperitoneal | 259mg/kg (259mg/kg) | Toxicology and Applied Pharmacology. Vol. 59, Pg. 424, 1981. | |
mouse | LD50 | intravenous | 261mg/kg (261mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 75, Pg. 78, 1942. | |
rat | LD50 | intravenous | 92mg/kg (92mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 83, Pg. 265, 1945. | |
rat | LD50 | oral | 66mg/kg (66mg/kg) | LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), DIFFUSE" | Toxicology and Applied Pharmacology. Vol. 18, Pg. 387, 1971. |
rat | LD50 | subcutaneous | 60mg/kg (60mg/kg) | Toxicology and Applied Pharmacology. Vol. 23, Pg. 470, 1972. | |
rat | LD50 | unreported | 60mg/kg (60mg/kg) | Cancer Research. Vol. 28, Pg. 2237, 1968. | |
rat | LDLo | intraperitoneal | 130mg/kg (130mg/kg) | LIVER: OTHER CHANGES LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Chemico-Biological Interactions. Vol. 12, Pg. 299, 1976. |